Drug Repurposing最新文献

筛选
英文 中文
Chapter 6. Screening Technologies 第六章。筛选技术
Drug Repurposing Pub Date : 1900-01-01 DOI: 10.1039/9781839163401-00101
F. Sheinerman
{"title":"Chapter 6. Screening Technologies","authors":"F. Sheinerman","doi":"10.1039/9781839163401-00101","DOIUrl":"https://doi.org/10.1039/9781839163401-00101","url":null,"abstract":"Screening advanced compounds enables discovery of direct repurposing candidates, novel drug-like leads for optimization, and informative pharmacological probes. In this chapter, we describe different types of screening collections used in drug repurposing, discuss issues and considerations in preparing and executing a repurposing screen, and present examples of in vitro and in vivo repurposing assays. We further describe various data sources reporting information on de-risked compounds of different types and illustrate how data mining and chemoinformatic and chemogenomic searches can be used to access large numbers of advanced compounds and assemble collections most suitable for screening in a given disease model. We argue that a view of repurposing screening as a large-scale bet on finding candidates for clinical testing is narrow and incomplete. Rather, when thoughtfully executed, screening of re-risked compounds is informed by target pathobiology and offers a means to efficiently convert advances in the development of sophisticated non-clinical models and new insights in disease mechanisms into novel drug-like leads and candidates for development.","PeriodicalId":202024,"journal":{"name":"Drug Repurposing","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130454540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chapter 1. Introduction and Historical Overview of Drug Repurposing Opportunities 第1章。药物再利用机会的介绍和历史概述
Drug Repurposing Pub Date : 1900-01-01 DOI: 10.1039/9781839163401-00001
S. Pushpakom
{"title":"Chapter 1. Introduction and Historical Overview of Drug Repurposing Opportunities","authors":"S. Pushpakom","doi":"10.1039/9781839163401-00001","DOIUrl":"https://doi.org/10.1039/9781839163401-00001","url":null,"abstract":"","PeriodicalId":202024,"journal":{"name":"Drug Repurposing","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124589194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Chapter 8. Using Artificial Intelligence for Drug Repurposing 第八章。使用人工智能进行药物再利用
Drug Repurposing Pub Date : 1900-01-01 DOI: 10.1039/9781839163401-00147
A. Bender
{"title":"Chapter 8. Using Artificial Intelligence for Drug Repurposing","authors":"A. Bender","doi":"10.1039/9781839163401-00147","DOIUrl":"https://doi.org/10.1039/9781839163401-00147","url":null,"abstract":"","PeriodicalId":202024,"journal":{"name":"Drug Repurposing","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117312127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chapter 12. Adapting Payers’ and Producers’ Incentives to Drug Repurposing 第十二章。调整支付方和生产者对药物再利用的激励
Drug Repurposing Pub Date : 1900-01-01 DOI: 10.1039/9781839163401-00244
A. Cole, B. Handelin, D. Cavalla
{"title":"Chapter 12. Adapting Payers’ and Producers’ Incentives to Drug Repurposing","authors":"A. Cole, B. Handelin, D. Cavalla","doi":"10.1039/9781839163401-00244","DOIUrl":"https://doi.org/10.1039/9781839163401-00244","url":null,"abstract":"","PeriodicalId":202024,"journal":{"name":"Drug Repurposing","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133010452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chapter 15. Future Perspectives in Drug Repurposing 第15章。药物再利用的未来展望
Drug Repurposing Pub Date : 1900-01-01 DOI: 10.1039/9781839163401-00301
D. Cavalla
{"title":"Chapter 15. Future Perspectives in Drug Repurposing","authors":"D. Cavalla","doi":"10.1039/9781839163401-00301","DOIUrl":"https://doi.org/10.1039/9781839163401-00301","url":null,"abstract":"Drug repurposing offers a more efficient route to medicinal innovation than conventional new molecular entity research, and proposals for repurposing projects can come from in silico algorithms, pharmacological experimentation, clinical serendipity or retrospective analysis of human data. These approaches offer a much larger number of hypotheses for validation than can be resourced, and rigorous multidisciplinary prioritisation is required. The recent COVID-19 pandemic has highlighted the potential for the approach, which has produced three clinically effective treatments in under a year, including two regulatory approvals for emergency use, and one drug with demonstrated efficacy against mortality. Challenges remain in how to provide additional commercial incentives for drug companies to support late-stage development of repurposing projects and fully realise its healthcare potential. © The Royal Society of Chemistry 2022.","PeriodicalId":202024,"journal":{"name":"Drug Repurposing","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129836158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信